Immunome IMNM Payment Of Offering Costs
Payment Of Offering Costs at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept imnm:PaymentOfOfferingCosts.
The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunome's payment of offering costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunome's payment of offering costs?
- Immunome (IMNM) reported payment of offering costs of $364K in Q1 2026.
- How has Immunome's payment of offering costs changed year-over-year?
- Immunome's payment of offering costs decreased by 96.5% year-over-year, from $10.49M to $364K.
- What does payment of offering costs mean?
- This represents the cash outflows incurred for professional fees, underwriting commissions, and other expenses directly related to raising capital through public or private offerings. It measures the friction cost of accessing capital markets. Investors monitor this to evaluate the efficiency of the company's capital-raising activities.